Stockscreener 앱 받기
5.62
4.18%
-0.30
전일 마감가:
$5.92
열려 있는:
$5.835
하루 거래량:
3.87M
Relative Volume:
0.99
시가총액:
$1.36B
수익:
$386.15M
순이익/손실:
$-56.39M
주가수익비율:
-24.43
EPS:
-0.23
순현금흐름:
$-55.19M
1주 성능:
+11.01%
1개월 성능:
+7.85%
6개월 성능:
+37.36%
1년 성능:
-3.69%
1일 변동 폭
$5.62
$6.04
1주일 범위
$4.91
$6.73
52주 변동 폭
$3.21
$6.78
Ardelyx Inc Stock (ARDX) Company Profile
명칭
Ardelyx Inc
전화
510-745-7047
주소
34175 ARDENWOOD BLVD., FREMONT, CA
ARDX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ARDX
Ardelyx Inc
|
5.625 | 1.44B | 386.15M | -56.39M | -55.19M | -0.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.33 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.05 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.90 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
830.71 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.73 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-03 | 재개 | Raymond James | Strong Buy |
| 2025-06-18 | 재개 | H.C. Wainwright | Buy |
| 2025-05-02 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2025-03-07 | 재개 | Ladenburg Thalmann | Buy |
| 2025-03-04 | 개시 | BTIG Research | Buy |
| 2024-11-11 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-07-02 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-04-05 | 개시 | Leerink Partners | Outperform |
| 2023-12-18 | 개시 | Raymond James | Strong Buy |
| 2023-09-07 | 개시 | H.C. Wainwright | Buy |
| 2023-08-25 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2023-03-03 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2022-11-17 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-05-06 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2021-12-01 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2021-10-14 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2021-07-21 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-07-20 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-07-20 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2021-03-23 | 개시 | Wedbush | Outperform |
| 2021-01-06 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-10-20 | 재개 | Citigroup | Buy |
| 2020-02-18 | 재개 | Jefferies | Buy |
| 2020-02-12 | 개시 | Citigroup | Buy |
| 2020-02-10 | 개시 | Cowen | Outperform |
| 2019-04-08 | 개시 | Piper Jaffray | Overweight |
| 2018-08-24 | 개시 | Jefferies | Buy |
| 2018-03-19 | 재개 | Leerink Partners | Outperform |
| 2017-11-29 | 재확인 | Citigroup | Buy |
| 2017-11-22 | 재확인 | Ladenburg Thalmann | Buy |
| 2017-10-17 | 재개 | Leerink Partners | Outperform |
| 2016-03-31 | 개시 | Ladenburg Thalmann | Buy |
| 2016-03-09 | 개시 | Cantor Fitzgerald | Buy |
| 2016-03-03 | 개시 | Citigroup | Buy |
모두보기
Ardelyx Inc 주식(ARDX)의 최신 뉴스
Ardelyx President and Chief Executive Officer Mike Raab to Participate in the Wedbush Rewind American Society of Nephrology 2025 Investor Conference - The Manila Times
Ardelyx (NASDAQ: ARDX) to join Wedbush Rewind ASN 2025; webcast, 30-day replay - Stock Titan
Why Upwork Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket - Benzinga
Combining machine learning predictions for Ardelyx Inc.Day Trade & Community Consensus Trade Alerts - newser.com
Can Ardelyx Inc. stock attract ESG capital inflowsJuly 2025 Levels & Verified Chart Pattern Signals - newser.com
Applying big data sentiment scoring on Ardelyx Inc.IPO Watch & Free Fast Gain Swing Trade Alerts - newser.com
Ardelyx Stock Slips After-Hours As $100M Shelf Filing Sparks Dilution Fears After Strong Q3 - Stocktwits
News impact scoring models applied to Ardelyx Inc.2025 Market Trends & Safe Swing Trade Setups - newser.com
Citigroup Raises Ardelyx (ARDX) Price Target to $11.00 with Buy Rating | ARDX Stock News - GuruFocus
Why Ardelyx Inc. stock could benefit from AI revolutionPortfolio Risk Summary & Real-Time Sentiment Analysis - newser.com
Can Ardelyx Inc. stock beat market expectations this quarterQuarterly Trade Report & Expert Verified Stock Movement Alerts - newser.com
HC Wainwright Forecasts Ardelyx's Q2 Earnings (NASDAQ:ARDX) - MarketBeat
Order flow analysis tools used on Ardelyx Inc.July 2025 Spike Watch & Free Reliable Trade Execution Plans - newser.com
How currency fluctuations impact Ardelyx Inc. stockForecast Cut & Growth-Oriented Investment Plans - newser.com
Ranking Ardelyx Inc. among high performing stocks via toolsJuly 2025 Market Mood & AI Driven Stock Price Forecasts - newser.com
Backtesting results for Ardelyx Inc. trading strategies2025 Winners & Losers & Low Risk Investment Opportunities - newser.com
Analyzing drawdowns of Ardelyx Inc. with statistical toolsQuarterly Earnings Report & Safe Capital Growth Stock Tips - newser.com
Is Ardelyx Inc. stock a safe investment in uncertain markets2025 Technical Patterns & Fast Entry High Yield Tips - newser.com
Should you hold or exit Ardelyx Inc. nowJuly 2025 Opening Moves & Weekly High Return Stock Forecasts - newser.com
Ardelyx (NASDAQ:ARDX) Releases Quarterly Earnings Results, Beats Expectations By $0.06 EPS - MarketBeat
Analyst Estimates: Here's What Brokers Think Of Ardelyx, Inc. (NASDAQ:ARDX) After Its Third-Quarter Report - simplywall.st
Ardelyx Stock Surges on Strong Q3 Performance and Future Optimism - StocksToTrade
Ardelyx Stock Soars After Beating Expectations: What’s Next? - timothysykes.com
Why Ardelyx (ARDX) Is Up 20.2% After Positive IBSRELA Patient Data at ACG 2025 Conference - Yahoo Finance
What high frequency data says about Ardelyx Inc.Trade Volume Summary & Weekly High Return Forecasts - newser.com
Ardelyx (NASDAQ:ARDX) Share Price Passes Above 50 Day Moving AverageHere's What Happened - MarketBeat
Forecasting Ardelyx Inc. price range with options dataJuly 2025 Review & Consistent Income Trade Ideas - newser.com
Is Ardelyx Inc. (41X) stock ideal for retirement investorsWall Street Watch & Safe Capital Growth Tips - newser.com
What analysts say about Ardelyx Inc stockSmall Cap Stock Opportunities & Affordable Portfolio Strategies - earlytimes.in
Ardelyx, Inc. (NASDAQ:ARDX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Ardelyx raises 2025 IBSRELA revenue guidance to $270M-$275M as growth accelerates - MSN
Ardelyx (NASDAQ:ARDX) Given New $10.00 Price Target at TD Cowen - MarketBeat
Investors Buy Large Volume of Call Options on Ardelyx (NASDAQ:ARDX) - MarketBeat
Ardelyx (NASDAQ:ARDX) Shares Gap UpShould You Buy? - MarketBeat
Ardelyx Stock Surges as Q3 Earnings Exceed Expectations - StocksToTrade
Ardelyx, Inc. (NASDAQ:ARDX) Q3 2025 Earnings Call Transcript - Insider Monkey
symbol__ Stock Quote Price and Forecast - CNN
Ardelyx Reports Strong Q3 Growth and Pipeline Expansion - The Globe and Mail
Ardelyx (ARDX): Forecasted 20% Revenue Growth and Profitability Timeline Shape Investor Expectations Ahead of Earnings - simplywall.st
Ardelyx Inc. Reports Strong Q3 Earnings Growth - TipRanks
Ardelyx (ARDX) Receives a Boost in Price Target from TD Cowen | - GuruFocus
Ardelyx Inc (41X.SG) stock price, news, quote and history - Yahoo! Finance Singapore
Ardelyx Shares Soar Premarket As CEO Sees Continued Demand For Blockbuster Drug Ibsrela - MSN
Ardelyx’s Strategic Growth and Pipeline Potential Justify Buy Rating - TipRanks
Ardelyx’s Strong Financial Performance and Growth Potential Drive Buy Rating - TipRanks
Is Ardelyx Inc. stock overvalued by current metricsMarket Growth Report & Community Consensus Picks - newser.com
Ardelyx: Q3 Earnings Snapshot - theheraldreview.com
Why Amazon Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket - Benzinga
Ardelyx Q3 Breakeven, Revenue Increases; Shares Rise Pre-Bell - MarketScreener
Will Ardelyx Inc. stock benefit from commodity pricesRate Hike & Safe Entry Point Alerts - newser.com
Ardelyx Inc (ARDX) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Market Challenges - Investing.com Canada
Ardelyx Inc (ARDX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.29%
0.56%
자본화:
|
볼륨(24시간):